UCHL3 and non-small cell lung carcinoma: Moreover, assessment of the Kaplan-Meier plotter (http://kmplot.com/analysis/) demonstrated that UCHL3 overexpression was associated with poor overall survival (OS, HR=1.65, logrank P=0.0082) and progression-free survival (PFS, HR=3.02, logrank P=0.00054) (Figure 1E, 1F), which indicated that increased expression of UCHL3 was associated with poor prognosis of patients with NSCLC.